Lanxess (LXS) PT Set at €48.00 by Independent Research
LXS has been the topic of several other reports. Morgan Stanley set a €54.00 ($62.79) price objective on Lanxess and gave the company a neutral rating in a research note on Tuesday, December 11th. DZ Bank reaffirmed a neutral rating on shares of Lanxess in a research note on Thursday, November 15th. Berenberg Bank set a €55.00 ($63.95) price objective on Lanxess and gave the company a sell rating in a research note on Wednesday, November 14th. Goldman Sachs Group set a €84.00 ($97.67) price objective on Lanxess and gave the company a buy rating in a research note on Monday, November 12th. Finally, Deutsche Bank set a €70.00 ($81.40) price objective on Lanxess and gave the company a buy rating in a research note on Tuesday, November 20th. Four investment analysts have rated the stock with a sell rating, eleven have assigned a hold rating and nine have given a buy rating to the company. Lanxess currently has a consensus rating of Hold and a consensus target price of €64.25 ($74.71).
Shares of ETR LXS traded down €0.69 ($0.80) during midday trading on Friday, hitting €45.69 ($53.13). The stock had a trading volume of 458,744 shares, compared to its average volume of 312,027. Lanxess has a 1-year low of €59.89 ($69.64) and a 1-year high of €74.50 ($86.63).
LANXESS Aktiengesellschaft, a specialty chemicals company, develops, manufactures, and markets chemical intermediates, specialty chemicals, and plastics worldwide. It operates in five segments: Advanced Intermediates, Specialty Additives, Performance Chemicals, Engineering Materials, and ARLANXEO. The Advanced Intermediates segment offers high-grade intermediates for the agrochemical and coating industries; fine chemicals as precursors and intermediates for the pharmaceutical, agrochemical, and specialty chemical industries; customer-specific specialties; organometallics; and tire chemicals.
Featured Article: Diversification in Investing
Receive News & Ratings for Lanxess Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lanxess and related companies with MarketBeat.com's FREE daily email newsletter.